Samih Abed Odhaib

Dr. Samih Abed Odhaib

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2022 in Medical Journal of the Islamic Republic Of Iran
Verified
Journal Article
Open access
PDF file
SOSamih Abed Odhaib
Samih Abed Odhaib
MMMiaad Jassim Mohammed
Miaad Jassim Mohammed
SHSaad Shaheen Hamadi
Saad Shaheen Hamadi
Background: The classic celiac disease (CD) presentation in individuals with iron deficiency anemia (IDA) has been changed given the large percentage of subtle or asymptomatic cases. The study objective was to assess the predictive factors influencing the diagnosis and severity of villous atrophy in individuals with CD and IDA ...

10 June 2022 in Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale
Verified
Journal Article
Open access
PDF file
OKOmer M. Kassid
Omer M. Kassid
SOSamih Abed Odhaib
Samih Abed Odhaib
MAMahmood Thamer Altemimi
Mahmood Thamer Altemimi
Flutamide is a non-steroidal anti-androgen drug effective in the management of prostatic carcinoma. The drug appears to be well tolerated with mild gastrointestinal adverse events and gynecomastia. Flutamide-induced hepatotoxicity may range from minor elevation in liver enzymes to hepatic failure. Here, we tried to discuss the possibility of hepatotoxicity induced by flutamide as antiandrogen therapy in a patient with prostatic adenocarcinoma. Here we present a 75-year-old man who commenced flutamide as a postoperative anti-androgen for prostatic adenocarcinoma for two months. He had markedly elevated levels of liver enzymes due to acute liver failure and subsequent multi-organ failure. The patient died after the failure of the resuscitation measures. The temporal relationship between the flutamide initiation and the emergence of hepatotoxicity is not clear, with a possible latency of 12-16 weeks. Careful monitoring of liver function test during flutamide therapy is essential to prevent serious hepatotoxicity.

25 November 2021 in Sultan Qaboos University Medical Journal
Verified
Journal Article
Open access
PDF file
SOSamih Abed Odhaib
Samih Abed Odhaib
MMMiaad J Mohammed
Miaad J Mohammed
AAAhmed Jh Al-Ali
Ahmed Jh Al-Ali
AMAbbas A Mansour
Abbas A Mansour
Mayer-Rokitansky-Küster-Hauser syndrome (MRKHS) or Müllerian agenesis represents uterovaginal aplasia or hypoplasia of unknown aetiology in young women with usual 46,XX karyotype and normal secondary sexual characteristics. We report a 15-year-old female patient who presented to a specialised diabetes endocrine and metabolism centre in Basrah, Iraq, in 2019 with primary amenorrhoea and normal pubertal secondary sexual characteristics, hormonal workup and clinical examination. Abdominopelvic magnetic resonance imaging (MRI) revealed cervical and uterine agenesis with the absence of the proximal thirds of the vagina. Both kidneys were fused in the right iliac fossa with oval lobulated appearance and crossed fused ectopia. The ovaries were normal and located bilaterally. The diagnosis of MRKHS type 2 was confirmed based on clinical, biochemical and radiological findings. The correct clinical and radiological diagnosis of MRKHS by MRI is crucial for long-term management.

26 April 2024 in Current Diabetes Reviews
Verified
Journal Article
Closed access
PDF file
SOSamih Abed Odhaib
Samih Abed Odhaib
AMAdel Gassab Mohammed
Adel Gassab Mohammed
HIHinde Iraqi
Hinde Iraqi
Since the authors are not responding to the editor’s requests to fulfill the editorial requirement, therefore, the article has beenwithdrawn from the journal "Current Diabetes Review".Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused.The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.phpBENTHAM SCIENCE DISCLAIMER:It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneouslysubmitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewheremust be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submittingthe article for publication the authors agree that the publishers have the legal right to take appropriate action against theauthors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyrightof their article is transferred to the publishers if and when the article is accepted for publication.

8 August 2025 in Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale
Verified
Journal Article
Open access
PDF file
SOSamih Abed Odhaib
Samih Abed Odhaib
MAMahmood Thamer Altemimi
Mahmood Thamer Altemimi
AMAbbas Ali Mansour
Abbas Ali Mansour
Thyroid dysfunction has been proposed as a potential contributor to Female Sexual Dysfunction (FSD), yet its impact, particularly in subclinical and autoimmune forms, remains controversial, especially in culturally conservative populations. This study aimed to assess the relationship between newly diagnosed thyroid dysfunction and sexual function among married, premenopausal women in Basrah, Iraq, using the Arabic version of the Female Sexual Function Index (FSFI). Out of 673 women aged 20–48 years presenting with sexual complaints, 229 with clinically confirmed FSD were enrolled. Of these, 42 were newly diagnosed with thyroid dysfunction, either overt or subclinical, autoimmune or non-autoimmune, and served as the case group. In contrast, 187 women with normal thyroid function served as controls. Hormonal profiling included Thyroid- Stimulating Hormone (TSH), Free Thyroxine (FT4), total testosterone (TT), Sex Hormone-Binding Globulin (SHBG), Calculated Free Testosterone (cFT), Estradiol (E2), and Prolactin (PRL). FSFI domain scores and hormonal parameters were compared across groups and subgroups. Subclinical and overt thyroid dysfunction were identified in 8.3% and 10.04% of the cohort, respectively. FSFI scores were significantly low across all domains in both groups. Although the orgasm domain (p=0.043) and total FSFI score (p=0.020) showed statistical significance, the overall clinical impact was limited due to the uniformly low scores. Hormonal levels, including PRL, TT, SHBG, cFT, and E2, did not differ significantly between groups, except for higher E2 levels among women with autoimmune thyroid dysfunction (p=0.026). No significant differences in FSFI scores were observed between autoimmune and non-autoimmune groups, or between autoimmune hypothyroidism and autoimmune hyperthyroidism. These findings suggest that thyroid dysfunction, whether overt, subclinical, or autoimmune, does not appear to be a major determinant of FSD in this population. The results support a multifactorial origin of FSD and underscore the need for culturally sensitive, interdisciplinary approaches to better understand and manage sexual health concerns among women in conservative societies.

19 March 2026 in Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale
Verified
Journal Article
Open access
PDF file
DADheyaa Kadhim Al-Waeli
Dheyaa Kadhim Al-Waeli
DMDR Adel Gassab Mohammed
DR Adel Gassab Mohammed
SOSamih Abed Odhaib
Samih Abed Odhaib
MAMahmood Thamer Altemimi
Mahmood Thamer Altemimi
SKShakir Aglah Khalifa
Shakir Aglah Khalifa
ITImad Hatim Tahir
Imad Hatim Tahir
The diagnostic performance of sonography to manage thyroid nodule (TN) may influence excess biopsy in different clinical settings. American College of Radiology (ACR) presented Thyroid Imaging Reporting and Data Systems (TIRADS) lator to American Thyroid Association (ATA) risk stratification guidelines, with variable diagnostic performance. The objective of this study is to evaluate the effectiveness of ACR-TIRADS versus ATA lexicons for thyroid cancer prediction among individuals with TN in Thi-Qar, Iraq. This cross-sectional observational study enrolled 1,007 individuals aged ≥ 14 years with 1,155 TNs attending a tertiary endocrine center. Malignancy risk was classified using both ACR-TIRADS and ATA lexicons with matched categories: TIRAD-1 (Benign<1%), TIRAD-2 (Very Low<3%), (TIRAD-3 (Low 5-10%), (TIRAD-4 (Intermediate 10-20%), and (TIRAD-5 (High 70-90%). Fine needle aspiration (FNAC) and histopathological diagnosis were made according to the Bethesda system and agreement between lexicons was assessed using sensitivity, specificity, Cohen’s Kappa Statistics, and McNemar test. Among participants, 85.2% were women, with mean age 46±14 years. Most individuals were euthyroid (71%), TNs were located in right lobe (51.3%), left lobe (42.5%), and isthmus (6.1%). FNAC was indicated for 54.6% of TNs by ATA and 44.6% by ACR-TIRADS criteria. High-risk cytology (Bethesda IV-V) was 7.1% and ATA system demonstrated higher sensitivity (74.3%) and accuracy (58.6%) than ACR-TIRADS (sensitivity 60%, accuracy 53%), though both gave modest diagnostic performance and low positive predictive values (<12%). Agreement between systems was weak (Cohen’s κ=0.265±0.032, p < 0.001), with concordance in 50.1% of cases. Both risk stratification systems had comparable but modest diagnostic performance. ATA identified more FNAC-eligible TNs with slightly higher sensitivity, specificity, prediction, and overall accuracy. However, the weak agreement between raters highlights variability in nodule categorization and management, supporting the need to integrate sonographic findings with clinical and biochemical factors to optimize TNs evaluation and minimize unnecessary biopsies.